144 related articles for article (PubMed ID: 8915820)
1. Thrombopoietin: biology, clinical applications, role in the donor setting.
Kuter DJ
J Clin Apher; 1996; 11(3):149-59. PubMed ID: 8915820
[TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin: biology and clinical potentials.
Miyazaki H; Kato T
Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin: Biology and Clinical Applications.
Kuter DJ
Oncologist; 1996; 1(1 & 2):98-106. PubMed ID: 10387974
[TBL] [Abstract][Full Text] [Related]
4. [Clinical use of thrombopoietin (c-Mpl Ligand)].
Borota R; Borota J; Belić A; Gebauer E; Stefanović N
Med Pregl; 1998; 51(11-12):501-8. PubMed ID: 10081270
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human thrombopoietin: clinical experience and in vivo biology.
Vadhan-Raj S
Semin Hematol; 1998 Jul; 35(3):261-8. PubMed ID: 9685172
[TBL] [Abstract][Full Text] [Related]
6. The structure, biology and potential therapeutic applications of recombinant thrombopoietin.
Lok S; Foster DC
Stem Cells; 1994 Nov; 12(6):586-98. PubMed ID: 7881359
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin: its role from early hematopoiesis to platelet production.
Wendling F
Haematologica; 1999 Feb; 84(2):158-66. PubMed ID: 10091415
[TBL] [Abstract][Full Text] [Related]
8. The role of platelet growth factors in cancer therapy.
Clarke K; Basser RL
Stem Cells; 1996; 14 Suppl 1():274-80. PubMed ID: 11012231
[TBL] [Abstract][Full Text] [Related]
9. Do the preclinical effects of thrombopoietin correlate with its in vitro properties?
Kaushansky K; Broudy VC; Sitnicka E; Lofton-Day C; Grossmann A; Sprugel K
Stem Cells; 1996; 14 Suppl 1():108-11. PubMed ID: 11012209
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
Newland A
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
[TBL] [Abstract][Full Text] [Related]
11. [Thrombopoietic growth factor--thrombopoietin. Molecular and biological properties].
Skotnicki AB; Jabłoński MJ
Przegl Lek; 1996; 53(11):826-9. PubMed ID: 9173448
[TBL] [Abstract][Full Text] [Related]
12. [Biology of thrombopoietin and its receptors].
Robak T
Postepy Hig Med Dosw; 1996; 50(6):649-63. PubMed ID: 9064684
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin (Mpl-ligand) and the regulation of platelet production.
Cohen-Solal K; Debili N; Vainchenker W; Wendling F
Thromb Haemost; 1997 Jul; 78(1):37-41. PubMed ID: 9198124
[TBL] [Abstract][Full Text] [Related]
14. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
[TBL] [Abstract][Full Text] [Related]
15. The physiological response of thrombopoietin (c-Mpl ligand) to thrombocytopenia in the rat.
Yang C; Li YC; Kuter DJ
Br J Haematol; 1999 May; 105(2):478-85. PubMed ID: 10233424
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin: biology and potential clinical applications.
Prow D; Vadhan-Raj S
Oncology (Williston Park); 1998 Nov; 12(11):1597-604, 1607-8; discussion 1611-4. PubMed ID: 9834938
[TBL] [Abstract][Full Text] [Related]
17. Clinical studies with megakaryocyte growth and development factor (Mpl-ligand).
Begley CG
Thromb Haemost; 1997 Jul; 78(1):42-6. PubMed ID: 9198125
[TBL] [Abstract][Full Text] [Related]
18. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
[TBL] [Abstract][Full Text] [Related]
19. Early Australian clinical studies with pegylated recombinant human megakaryocyte growth and development factor.
Basser RL
Stem Cells; 1998; 16 Suppl 2():225-9. PubMed ID: 11012194
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.
Wolff SN; Herzig R; Lynch J; Ericson SG; Greer JP; Stein R; Goodman S; Benyunes MC; Ashby M; Jones DV; Fay J
Bone Marrow Transplant; 2001 Feb; 27(3):261-8. PubMed ID: 11277173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
